caveolin-1 peptide is used for blocking the activity of Caveolin-1 antibody - the-ordinary-peptide-lash-serum-review by the CAV1 gene The Multifaceted Role of Caveolin-1 Peptides in Cellular Regulation and Therapeutic Potential

catalog-peptide The exploration of caveolin-1 peptide has revealed its significant and diverse roles within cellular processes, positioning it as a compelling area of research with considerable therapeutic promise. Caveolin-1 (Cav1), a key structural and functional protein, forms the backbone of caveolae, flask-shaped invaginations of the plasma membrane. These specialized microdomains are central to a wide array of cellular functions, including transcytosis, endocytosis, and signal transduction. Understanding the intricate mechanisms orchestrated by caveolin-1 and its associated peptides is crucial for unlocking their potential in treating various diseases.

At its core, caveolin-1 (CAV1) acts as a molecular hub, a critical nexus that integrates and regulates multiple signaling pathways. This regulatory capacity stems from its ability to interact with and influence the activity of numerous proteins, including a wide range of kinases and other enzymesDissecting the molecular control of endothelial NO .... One well-documented interaction involves endothelial NO synthase (eNOS), where caveolin-1 negatively regulates its activity, thereby impacting cellular nitric oxide (NO) release.Caveolin 1 This nuanced control of NO production is vital for vascular health and other physiological processes. Research has explored caveolin-1 scaffolding domain peptide designs that blocks eNOS activity and cellular NO release in vitro, demonstrating a direct impact on this pathway.

The caveolin-1 scaffolding domain itself is a region of particular interest. This domain, often referred to as the CSD, plays a pivotal role in mediating caveolin-1's interactions. Specific caveolin-1 scaffolding domain peptides, such as CSP7 (caveolin-1–derived peptide, CSP7), have emerged as significant research subjectsForms a stable heterooligomeric complex with CAV2that targets to lipid rafts and drives caveolae formation.. These peptides have shown promise in several disease models作者：S Aoki·2012·被引用次数：23—Caveolin-1 has a segment of hydrophobic amino acidscomprising approximately residues 103–122 that are anchored to the membrane with cholesterol-rich .... For instance, studies have indicated that caveolin-1 scaffolding domain peptide can have beneficial anti-inflammatory effects by restoring the activity of heme oxygenase-1 (HO-1) that is suppressed by Cav-1 on the plasma membrane. Furthermore, caveolin-1 scaffolding domain peptide has demonstrated the ability to reverse aging-associated fibrosis, microvascular leakage, and organ damage. This suggests a broad protective and restorative capacity at the cellular level.

The genetic basis for caveolin-1 is encoded by the CAV1 gene.作者：DN Das·2023·被引用次数：12—Caveolin‐1 (CAV1) is the structural protein component of caveolae which are vesicular invaginations of the plasma membrane. CAV1 participates in signal ... This gene's expression and the resulting protein's function are fundamental to cellular architecture and signaling networks. The CAV1 gene provides the blueprint for a protein that forms a stable heterooligomeric complex with CAV2, which then targets to lipid rafts and drives caveolae formation. This complex assembly is essential for the characteristic invaginations of the plasma membrane.

The therapeutic implications of caveolin-1 peptide are rapidly expanding. The protein is recognized as an emerging therapeutic target in the effective treatment of IPF (idiopathic pulmonary fibrosis). Specific caveolin-1 (Cav-1) peptides are being investigated for their ability to mitigate the progression of fibrotic lung diseases. For example, caveolin-1 scaffolding domain peptide (CSP) has been found to alleviate pulmonary fibrosis in various animal models and has been explored for its role in reducing ER stress.Caveolin-1 is an aggresome-inducing protein | Scientific Reports - Nature The development of caveolin-1-derived peptide limits development of pulmonary fibrosis, particularly through compounds like CSP7, offers a potential avenue for treating interstitial lung diseases.Pre-clinical proof-of-concept of anti-fibrotic activity of ...

Beyond lung diseases, caveolin-1 and its peptide derivatives are implicated in other conditions.Caveolin-1 and Liver Regeneration: Role in Proliferation and Lipogenesis Their role in liver regeneration, particularly in regulating proliferation and lipogenesis, highlights their metabolic significance. Research also indicates that caveolin-1 is an aggresome-inducing protein, adding another layer to its complex cellular functions. Furthermore, caveolin-1 and its regulation of cellular cholesterol homeostasis underscore its importance in lipid metabolism.Dissecting the molecular control of endothelial NO ...

In the context of oncology, caveolin1 plays a complex role in glioblastoma (GBM), demonstrating both tumor-promoting and tumor-suppressing activities depending on the cellular context.Pre-clinical proof-of-concept of anti-fibrotic activity of ... This duality emphasizes the need for precise targeting when considering caveolin-1 peptide therapies.

The development of practical applications for these peptides often involves specific formulations and delivery methods.Caveolin-1 scaffolding domain peptides enhance anti ... Cell permeable peptides are particularly valuable, allowing for intracellular action. These cell permeable peptides can block eNOS activity and cellular NO release in vitro and reduce inflammation and tumorigenesis in vivo. This includes efforts to create dry powder formulations of caveolin-1 peptides.

For researchers and scientists, understanding the precise nature of these peptides is often accompanied by the need for specific research tools2024年4月28日—Caveolin-1 (CAV-1) is an integral membrane protein, which, via its caveolin scaffolding domain (CSD), interacts with caveolin binding domains ( .... For instance, a caveolin-1 peptide may be utilized for blocking the activity of Caveolin-1 antibody, facilitating experimental validation and mechanistic studies. The availability of technical info / product notes is crucial for proper handling and storage, ensuring reproducible experimental outcomes.

The structural characteristics of caveolin-1 are also critical to its functionin the formation and function of caveolae.Caveolin-1scaffolding domainpeptidecan reverse aging associated fibrosis, microvascular leakage, and organ .... Caveolin-1 has a segment of hydrophobic amino acids, comprising approximately residues 103–122, which are anchored to the membrane within cholesterol-rich domains. This interaction with the lipid bilayer is fundamental to its localization and function within caveolae. Studies exploring three caveolin-1 peptides, including the scaffolding domain (residues 83–101), a water-insoluble construct, and a water-soluble variant, further delineate the structure-function relationships of these molecules.Caveolin-1 scaffolding domain peptide

In summary, the field of caveolin-1 peptide research is dynamic and multifaceted.Caveolin-1 Peptideis used for blocking the activity of Caveolin-1 antibody(catalog number 45-027). The Caveolin-1 antibody ships at 0.5 mg/mL and the ... From fundamental cellular processes like signal transduction and lipid metabolism to its potential as a therapeutic agent in conditions ranging from pulmonary fibrosis to cancer, caveolin-1 and its peptide fragments represent a significant frontier in biological and medical science. Continued investigation into their precise mechanisms of action and the development of targeted peptide therapies promise exciting advancements in human health作者：S Venkatesan·2022·被引用次数：9—Cav1 acts as a molecular hub that integrates and regulates multiple signaling pathwaysincluding the transforming growth factor-beta (TGF-β) ....